{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T10:00:16Z","timestamp":1766052016561,"version":"3.48.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,18]]},"DOI":"10.7759\/cureus.99524","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T09:56:21Z","timestamp":1766051781000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical and Epidemiological Profile and Treatment Outcomes of Tuberculous Cervical Lymphadenitis: A Hospital-Based Observational Study"],"prefix":"10.7759","author":[{"given":"Praveen","family":"Nayak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishnukanth","family":"Govindaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dharm Prakash","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noyal M","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. P.","family":"Elamurugan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhusmita","family":"Mohanty Mohapatra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manju","family":"Rajaram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pratap","family":"Upadhya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinod Kumar","family":"Saka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"WHO global tuberculosis report 2020. (2020). Accessed. June 23, 2025: https:\/\/www.who.int\/publications\/i\/item\/9789240013131."},{"key":"ref2","unstructured":"WHO global TB report. (2024). Accessed. November 29, 2025: https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2024."},{"key":"ref3","unstructured":"India TB report 2024. (2025). https.\/\/tbcindia.mohfw.gov.in\/wp-content\/uploads\/2024\/10\/TB-Report_for-Web_08_10-2024-1.pdf."},{"key":"ref4","unstructured":"India TB report 2024 - Central Tuberculosis Division. (2024). Accessed. November 29, 2025: https:\/\/tbcindia.mohfw.gov.in\/wp-content\/uploads\/2024\/10\/TB-Report_for-Web_08_10-2024-1.pdf."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/tcmj.tcmj_86_22","article-title":"Role of GeneXpert MTB\/RIF assay for the diagnosis of cervical lymph node tuberculosis and rifampicin resistance","volume":"34","author":"Mukhida S","year":"2022","unstructured":"Mukhida S, Vyawahare CR, Mirza SB, Gandham NR, Khan S, Kannuri S, Bhaumi S. Role of GeneXpert MTB\/RIF assay for the diagnosis of cervical lymph node tuberculosis and rifampicin resistance. Tzu Chi Med J. 2022, 34:418-22. 10.4103\/tcmj.tcmj_86_22","journal-title":"Tzu Chi Med J"},{"key":"ref6","article-title":"Utility of CBNAAT, cytology and histology in diagnosis of suspected tubercular solid lymph node","volume":"5","author":"Manju MD","year":"2020","unstructured":"Manju MD, Madhusudhan AV. Utility of CBNAAT, cytology and histology in diagnosis of suspected tubercular solid lymph node. Indian J Immunol Respir Med. 2020, 5:168-72.","journal-title":"Indian J Immunol Respir Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.52.1","article-title":"Granulomatous lymphadenitis","volume":"52","author":"Asano S","year":"2012","unstructured":"Asano S. Granulomatous lymphadenitis. J Clin Exp Hematop. 2012, 52:1-16. 10.3960\/jslrt.52.1","journal-title":"J Clin Exp Hematop"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jctube.2023.100390","article-title":"Clinical features, resistance patterns and treatment outcomes of drug-resistant extra-pulmonary tuberculosis: a scoping review","volume":"33","author":"Miiro E","year":"2023","unstructured":"Miiro E, Olum R, Baluku JB. Clinical features, resistance patterns and treatment outcomes of drug-resistant extra-pulmonary tuberculosis: a scoping review. J Clin Tuberc Other Mycobact Dis. 2023, 33:100390. 10.1016\/j.jctube.2023.100390","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4507-0","article-title":"Characteristics of residual lymph nodes after six months of antituberculous therapy in HIV-negative individuals with cervical tuberculous lymphadenitis","volume":"19","author":"Seok H","year":"2019","unstructured":"Seok H, Jeon JH, Oh KH, et al.. Characteristics of residual lymph nodes after six months of antituberculous therapy in HIV-negative individuals with cervical tuberculous lymphadenitis. BMC Infect Dis. 2019, 19:867. 10.1186\/s12879-019-4507-0","journal-title":"BMC Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s42047-022-00111-z","article-title":"Combination method for the diagnosis of tuberculous lymphadenitis in high burden settings","volume":"5","author":"Shetty D","year":"2022","unstructured":"Shetty D, Vyas D. Combination method for the diagnosis of tuberculous lymphadenitis in high burden settings. Surg Exp Pathol. 2022, 5:10.1186\/s42047-022-00111-z","journal-title":"Surg Exp Pathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.12669\/pjms.323.9550","article-title":"Cervical tuberculous lymphadenitis: clinico-demographic profiles of patients in a secondary level hospital of Bangladesh","volume":"32","author":"Kamal MS","year":"2016","unstructured":"Kamal MS, Hoque MH, Chowdhury FR, Farzana R. Cervical tuberculous lymphadenitis: clinico-demographic profiles of patients in a secondary level hospital of Bangladesh. Pak J Med Sci. 2016, 32:608-12. 10.12669\/pjms.323.9550","journal-title":"Pak J Med Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jctube.2023.100384","article-title":"Clinical characteristics and outcome of tuberculosis lymphadenitis in a tertiary center from Saudi Arabia","volume":"33","author":"Algarni A","year":"2023","unstructured":"Algarni A, Alansari N, Alqurashi M, Alsaeed M. Clinical characteristics and outcome of tuberculosis lymphadenitis in a tertiary center from Saudi Arabia. J Clin Tuberc Other Mycobact Dis. 2023, 33:100384. 10.1016\/j.jctube.2023.100384","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.07.011","article-title":"Clinical features of tuberculous lymphadenitis in a low-incidence country","volume":"98","author":"Mathiasen VD","year":"2020","unstructured":"Mathiasen VD, Andersen PH, Johansen IS, Lillebaek T, Wejse C. Clinical features of tuberculous lymphadenitis in a low-incidence country. Int J Infect Dis. 2020, 98:366-71. 10.1016\/j.ijid.2020.07.011","journal-title":"Int J Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2008.06.046","article-title":"Gender differences in the clinical diagnosis of tuberculous lymphadenitis--a hospital-based study from Central India","volume":"13","author":"Purohit MR","year":"2009","unstructured":"Purohit MR, Mustafa T, M\u00f8rkve O, Sviland L. Gender differences in the clinical diagnosis of tuberculous lymphadenitis--a hospital-based study from Central India. Int J Infect Dis. 2009, 13:600-5. 10.1016\/j.ijid.2008.06.046","journal-title":"Int J Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.9790\/0853-1901122225","article-title":"Clinicopathological study of lateral neck swellings- a prospective study in CMCH","volume":"19","author":"Jayakumar R","year":"2020","unstructured":"Jayakumar R, Thenmozhi K, Naveen M and Abirami K. Clinicopathological study of lateral neck swellings- a prospective study in CMCH. IOSR J Dent Med Sci. 2020, 19:22-5. 10.9790\/0853-1901122225","journal-title":"IOSR J Dent Med Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.18203\/2349-2902.isj20190407","article-title":"A clinical study of tuberculous cervical lymphadenopathy: surgeon\u2019s perspectives","volume":"6","author":"Patel K","year":"2019","unstructured":"Patel K. A clinical study of tuberculous cervical lymphadenopathy: surgeon\u2019s perspectives. Int Surg J. 2019, 6:581-5. 10.18203\/2349-2902.isj20190407","journal-title":"Int Surg J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.23958\/ijirms\/vol03-i12\/494","article-title":"Clinicopathological correlation in patients of lymphadenopathy in tertiary care hospital","volume":"3","author":"Amol R","year":"2018","unstructured":"Amol R, Deepak H. Clinicopathological correlation in patients of lymphadenopathy in tertiary care hospital. Int J Innov Res Med Sci. 2018, 3:2336-9. 10.23958\/ijirms\/vol03-i12\/494","journal-title":"Int J Innov Res Med Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4103\/0300-1652.182077","article-title":"Tuberculous lymphadenopathy: experience from the referral center of Northern India","volume":"57","author":"Singh SK","year":"2016","unstructured":"Singh SK, Tiwari KK. Tuberculous lymphadenopathy: experience from the referral center of Northern India. Niger Med J. 2016, 57:134-8. 10.4103\/0300-1652.182077","journal-title":"Niger Med J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.5455\/2349-3933.ijam20150505","article-title":"Human immunodeficiency virus associated tuberculous lymphadenitis: a clinical study of 50 cases of Saurastra region of Gujarat, India","volume":"2","author":"Damor P","year":"2015","unstructured":"Damor P, Thakor N, Baranda U, et al.. Human immunodeficiency virus associated tuberculous lymphadenitis: a clinical study of 50 cases of Saurastra region of Gujarat, India. Int J Adv Med. 2015, 2:100. 10.5455\/2349-3933.ijam20150505","journal-title":"Int J Adv Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4103\/jdrysruhs.jdrysruhs_32_24","article-title":"Efficacy of Tru\u2011cut biopsy of the cervical lymphnodes over FNAC for detecting MTB using CBNAAT histopathology and cultures","volume":"13","author":"Basith AM","year":"2024","unstructured":"Basith AM, Aleemuddin NM, Hasan A, Abdullah F, Mahmood S, Ali AM. Efficacy of Tru\u2011cut biopsy of the cervical lymphnodes over FNAC for detecting MTB using CBNAAT histopathology and cultures. J YSR Univ Health Sci. 2024, 13:247-52. 10.4103\/jdrysruhs.jdrysruhs_32_24","journal-title":"J YSR Univ Health Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.14744\/nci.2016.20982","article-title":"Diagnostic challenges in cervical tuberculous lymphadenitis: a review","volume":"3","author":"Deveci HS","year":"2016","unstructured":"Deveci HS, Kule M, Kule ZA, Habesoglu TE. Diagnostic challenges in cervical tuberculous lymphadenitis: a review. North Clin Istanb. 2016, 3:150-5. 10.14744\/nci.2016.20982","journal-title":"North Clin Istanb"},{"key":"ref22","unstructured":"Extrapulmonary tb training module. (2023). https.\/\/tbcindia.mohfw.gov.in\/wp-content\/uploads\/2023\/05\/7702334778Training_Module_on_Extrapulmonary_TB_-_Book_240320...."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/pmj.77.905.185","article-title":"Cervical tuberculous lymphadenopathy: changing clinical pattern and concepts in management","volume":"77","author":"Jha BC","year":"2001","unstructured":"Jha BC, Dass A, Nagarkar NM, Gupta R, Singhal S. Cervical tuberculous lymphadenopathy: changing clinical pattern and concepts in management. Postgrad Med J. 2001, 77:185-7. 10.1136\/pmj.77.905.185","journal-title":"Postgrad Med J"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4103\/picr.picr_20_24","article-title":"Incidence of adverse drug reactions among tuberculosis patients initiated on daily drug regimen in a southern district of Karnataka","volume":"16","author":"Kumar RN","year":"2025","unstructured":"Kumar RN, Rao CR, Maradi R, Umakanth S, Sanju SV, Balu PS. Incidence of adverse drug reactions among tuberculosis patients initiated on daily drug regimen in a southern district of Karnataka. Perspect Clin Res. 2025, 16:31-7. 10.4103\/picr.picr_20_24","journal-title":"Perspect Clin Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.7860\/jcdr\/2022\/57878.16719","article-title":"Adverse drug reactions to a daily fixed-dose combination based antituberculosis treatment regime in India\u2019s National Tuberculosis Elimination Programme: a prospective cohort study.","volume":"16","author":"Mate K","year":"2022","unstructured":"Mate K, Mishra G, Munje R. Adverse drug reactions to a daily fixed-dose combination based antituberculosis treatment regime in India\u2019s National Tuberculosis Elimination Programme: a prospective cohort study. . J Clin Diagnost Res. 2022, 16:14-9. 10.7860\/jcdr\/2022\/57878.16719","journal-title":"J Clin Diagnost Res"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199911000-00001","article-title":"Hypersensitivity reactions to rifampin. Pathogenetic mechanisms, clinical manifestations, management strategies, and review of the anaphylactic-like reactions","volume":"78","author":"Mart\u00ednez E","year":"1999","unstructured":"Mart\u00ednez E, Collazos J, Mayo J. Hypersensitivity reactions to rifampin. Pathogenetic mechanisms, clinical manifestations, management strategies, and review of the anaphylactic-like reactions. Medicine (Baltimore). 1999, 78:361-9. 10.1097\/00005792-199911000-00001","journal-title":"Medicine (Baltimore)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2025\/76049.20464","article-title":"A rare case of rifampicin-induced drug reaction with eosinophilia and systemic symptoms syndrome","volume":"4","author":"Kumar S","year":"2024","unstructured":"Kumar S, Chander A, Taneja S, Purohit CS. A rare case of rifampicin-induced drug reaction with eosinophilia and systemic symptoms syndrome. J Adv Lung Health. 2024, 4:29-31. 10.7860\/JCDR\/2025\/76049.20464","journal-title":"J Adv Lung Health"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2007.05207.x","article-title":"Antituberculosis drug-induced hepatotoxicity: concise up-to-date review","volume":"23","author":"Tostmann A","year":"2008","unstructured":"Tostmann A, Boeree MJ, Aarnoutse RE, de Lange WC, van der Ven AJ, Dekhuijzen R. Antituberculosis drug-induced hepatotoxicity: concise up-to-date review. J Gastroenterol Hepatol. 2008, 23:192-202. 10.1111\/j.1440-1746.2007.05207.x","journal-title":"J Gastroenterol Hepatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/S0377-1237(06)80155-3. 1237(06)80155-3","article-title":"Risk factors of hepatotoxicity during anti-tuberculosis treatment","volume":"62","author":"Anand AC","year":"2006","unstructured":"Anand AC, Seth AK, Paul M, Puri P. Risk factors of hepatotoxicity during anti-tuberculosis treatment. Med J Armed Forces India. 2006, 62:45-9. 10.1016\/S0377-1237(06)80155-3. 1237(06)80155-3","journal-title":"Med J Armed Forces India"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/380123-clinical-and-epidemiological-profile-and-treatment-outcomes-of-tuberculous-cervical-lymphadenitis-a-hospital-based-observational-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T09:56:26Z","timestamp":1766051786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/380123-clinical-and-epidemiological-profile-and-treatment-outcomes-of-tuberculous-cervical-lymphadenitis-a-hospital-based-observational-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.99524","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,18]]}}}